Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523365 | SCV000619284 | uncertain significance | not provided | 2017-07-25 | criteria provided, single submitter | clinical testing | The L1501F variant in the LRP4 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The L1501F variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The L1501F variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret L1501F as a variant of uncertain significance. |
Fulgent Genetics, |
RCV002490911 | SCV002787413 | uncertain significance | Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome 17 | 2022-01-04 | criteria provided, single submitter | clinical testing |